Ignite Creation Date:
2025-12-25 @ 2:59 AM
Ignite Modification Date:
2026-03-05 @ 6:03 PM
Study NCT ID:
NCT00290433
Status:
COMPLETED
Last Update Posted:
2020-09-23
First Post:
2006-02-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell Lymphoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lymphoma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Lymphoma | View |
| None | Peripheral T Cell | View |
| None | HCVIDDOXIL Regimen | View |
| None | ARA-C | View |
| None | Cytosar | View |
| None | DepoCyt | View |
| None | Cytosine arabinosine hydrochloride | View |
| None | Pegylated Liposomal Doxorubicin | View |
| None | Doxorubicin hydrochloride | View |
| None | Doxil | View |
| None | Cyclophosphamide | View |
| None | Cytoxan | View |
| None | Neosar | View |
| None | Dexamethasone | View |
| None | Decadron | View |
| None | Mesna | View |
| None | Methotrexate | View |
| None | Vincristine | View |
| None | G-CSF | View |
| None | Filgrastim | View |
| None | Neupogen | View |